Currently, I author and help develop regulatory content strategy at Janssen Pharmaceuticals for global CMC dossier submissions, including vaccines and novel biotherapeutic platforms, such as protein-drug conjugates, antibody-drug conjugates, DNA plasmids, gene therapy vaccines, and bispecific antibodies (Duobody) technology.
Education
Ph.D. in Biomedical Sciences, University of Central Florida
Languages
English
Spanish
Portuguese
For questions, comments, or anything else, I can be contacted at BrianDow2@gmail.com
To learn more about me, see my LinkedIn and Twitter.
Modern Biological & Chemical Threats 